$RCKT News Article - Rocket Pharmaceuticals to Present Preliminary Phase 1 Data of RP-L102 "Process B" for Fanconi Anemia at the 61st American Society of Hematology Annual Meeting https://marketwirenews.com/news-releases/rock...00219.html
(0)
(0)
Rocket Pharmaceuticals, Inc. (RCKT) Stock Research Links